Completed
Studies of Ocular Complications of AIDS SOCA
Led by Johns Hopkins Bloomberg School of Public Health · Updated on 2015-06-12
2392
Participants Needed
19
Research Sites
N/A
Total Duration
On this page
Sponsors
J
Johns Hopkins Bloomberg School of Public Health
Lead Sponsor
N
National Eye Institute (NEI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
To monitor trends over time, in the incidence of CMV retinitis and other ocular complications of AIDS To determine the effect of highly active anti-retroviral therapy (HAART)-induced immune status on the risk of developing CMV retinitis and other ocular complications of AIDS To determine the characteristics (clinical, virologic, hematologic, and biochemical) of a population at high risk for CMV retinitis and other ocular complications of AIDS To evaluate the effects of treatments for CMV retinitis and other ocular complications on visual function, quality of life, and survival.
CONDITIONS
Brief Title
Longitudinal Study of Ocular Complications of AIDS (LSOCA)
Who Can Participate
Eligibility Criteria
Inclusion criteria:
- A diagnosis of AIDS according to the 1993 Centers for Disease Control and Prevention (CDC) definition (with or without clinical symptoms of CMV retinitis or other ocular complications of AIDS)
- Age 13 years or older
- Signed consent statement
- Patients with newly diagnosed (within 45 days of enrollment) Ocular Opportunistic Infections (OOIs)
- Patients without a newly diagnosed Ocular Opportunistic Infection (OOI) diagnosed with AIDS after 1 Jan 2001
Exclusion criteria:
- none.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here